⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for unresectable head and neck squamous cell carcinoma

Every month we try and update this database with for unresectable head and neck squamous cell carcinoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
A Clinical Trial Investigating the Safety, Tolerability, and Therapeutic Effects of BNT113 in Combination With Pembrolizumab Versus Pembrolizumab Alone for Patients With a Form of Head and Neck Cancer Positive for Human Papilloma Virus 16 and Expressing the Protein PD-L1NCT04534205
Unresectable He...
Metastatic Head...
Recurrent Head ...
BNT113
Pembrolizumab
18 Years - BioNTech SE
Image-guided Proton Therapy for the Treatment of Locally Advanced Unresectable Head and Neck CancerNCT04870840
Locally Advance...
Locally Advance...
Locally Advance...
Locally Advance...
Locally Advance...
Locally Advance...
Malignant Poste...
Stage II Cutane...
Stage II Hypoph...
Stage II Laryng...
Stage II Nasoph...
Stage II Oropha...
Stage III Cutan...
Stage III Hypop...
Stage III Laryn...
Stage III Nasop...
Stage III Oroph...
Unresectable He...
Unresectable Or...
Proton Beam Rad...
Quality-of-Life...
Questionnaire A...
18 Years - M.D. Anderson Cancer Center
Re-irradiation With NBTXR3 in Combination With Pembrolizumab for the Treatment of Inoperable Locoregional Recurrent Head and Neck Squamous Cell CancerNCT04834349
Recurrent Head ...
Unresectable He...
Hafnium Oxide-c...
Intensity-Modul...
Intensity-Modul...
Pembrolizumab
Quality-of-Life...
Questionnaire A...
Stereotactic Bo...
18 Years - M.D. Anderson Cancer Center
Cetuximab and Recombinant Interleukin-12 in Treating Patients With Squamous Cell Carcinoma of the Head and Neck That is Recurrent, Metastatic, or Cannot Be Removed by SurgeryNCT01468896
Metastatic Head...
Recurrent Head ...
Unresectable He...
Cetuximab
Edodekin alfa
Laboratory Biom...
18 Years - National Cancer Institute (NCI)
Optimizing Antitumor Immunity Using Plasmid Electroporation, Pembrolizumab, and EpacadostatNCT03823131
Metastatic Head...
Recurrent Head ...
Unresectable He...
ImmunoPulse
Epacadostat
Pembrolizumab
CORVax
Tavokinogene te...
18 Years - University of California, San Francisco
Image-guided Proton Therapy for the Treatment of Locally Advanced Unresectable Head and Neck CancerNCT04870840
Locally Advance...
Locally Advance...
Locally Advance...
Locally Advance...
Locally Advance...
Locally Advance...
Malignant Poste...
Stage II Cutane...
Stage II Hypoph...
Stage II Laryng...
Stage II Nasoph...
Stage II Oropha...
Stage III Cutan...
Stage III Hypop...
Stage III Laryn...
Stage III Nasop...
Stage III Oroph...
Unresectable He...
Unresectable Or...
Proton Beam Rad...
Quality-of-Life...
Questionnaire A...
18 Years - M.D. Anderson Cancer Center
Re-irradiation With NBTXR3 in Combination With Pembrolizumab for the Treatment of Inoperable Locoregional Recurrent Head and Neck Squamous Cell CancerNCT04834349
Recurrent Head ...
Unresectable He...
Hafnium Oxide-c...
Intensity-Modul...
Intensity-Modul...
Pembrolizumab
Quality-of-Life...
Questionnaire A...
Stereotactic Bo...
18 Years - M.D. Anderson Cancer Center
Image-guided Proton Therapy for the Treatment of Locally Advanced Unresectable Head and Neck CancerNCT04870840
Locally Advance...
Locally Advance...
Locally Advance...
Locally Advance...
Locally Advance...
Locally Advance...
Malignant Poste...
Stage II Cutane...
Stage II Hypoph...
Stage II Laryng...
Stage II Nasoph...
Stage II Oropha...
Stage III Cutan...
Stage III Hypop...
Stage III Laryn...
Stage III Nasop...
Stage III Oroph...
Unresectable He...
Unresectable Or...
Proton Beam Rad...
Quality-of-Life...
Questionnaire A...
18 Years - M.D. Anderson Cancer Center
Cetuximab and Recombinant Interleukin-12 in Treating Patients With Squamous Cell Carcinoma of the Head and Neck That is Recurrent, Metastatic, or Cannot Be Removed by SurgeryNCT01468896
Metastatic Head...
Recurrent Head ...
Unresectable He...
Cetuximab
Edodekin alfa
Laboratory Biom...
18 Years - National Cancer Institute (NCI)
Trigriluzole With Nivolumab and Pembrolizumab in Treating Patients With Metastatic or Unresectable Solid Malignancies or LymphomaNCT03229278
Lymphoma
Metastatic Mali...
Metastatic Mela...
Metastatic Rena...
Recurrent Bladd...
Recurrent Class...
Recurrent Head ...
Recurrent Lymph...
Recurrent Malig...
Recurrent Renal...
Stage III Bladd...
Stage III Lymph...
Stage III Non-S...
Stage III Renal...
Stage III Skin ...
Stage IIIA Non-...
Stage IIIA Skin...
Stage IIIB Non-...
Stage IIIB Skin...
Stage IIIC Skin...
Stage IV Bladde...
Stage IV Lympho...
Stage IV Non-Sm...
Stage IV Renal ...
Stage IV Skin M...
Stage IVA Bladd...
Stage IVB Bladd...
Unresectable He...
Unresectable So...
Enzyme Inhibito...
Laboratory Biom...
Nivolumab
Pembrolizumab
18 Years - Rutgers, The State University of New Jersey
Testing the Addition of an Anti-cancer Drug, BAY 1895344, With Radiation Therapy to the Usual Pembrolizumab Treatment for Recurrent Head and Neck CancerNCT04576091
Clinical Stage ...
Clinical Stage ...
Recurrent Cutan...
Recurrent Head ...
Recurrent Hypop...
Recurrent Laryn...
Recurrent Oral ...
Recurrent Oroph...
Recurrent Paran...
Recurrent Saliv...
Stage III Cutan...
Stage III Hypop...
Stage III Laryn...
Stage III Lip a...
Stage III Major...
Stage III Oroph...
Stage III Sinon...
Stage IV Cutane...
Stage IV Hypoph...
Stage IV Laryng...
Stage IV Lip an...
Stage IV Major ...
Stage IV Oropha...
Stage IV Sinona...
Unresectable Cu...
Unresectable He...
Unresectable Hy...
Unresectable La...
Unresectable Or...
Unresectable Or...
Unresectable Pa...
Unresectable Sa...
Biospecimen Col...
Computed Tomogr...
Elimusertib
Pembrolizumab
Positron Emissi...
Quality-of-Life...
Stereotactic Bo...
18 Years - National Cancer Institute (NCI)
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: